Completed Trials

Participate in a trial

The Clinical Trial Unit provides participants the opportunity to participate in clinical research within a supportive and safe environment. We are always looking for healthy volunteers and participants with health conditions to volunteer for a wide variety of trials. If you are interested in participating in our clinical trials please register your interest and you will be notified by email when a new trial becomes available for which you may be eligible. Alternatively please look through our list of current trials below and register for specific studies.

Completed Trials

	A potential new treatment for symptoms of anxiety and stress in adults with chronic pain We are conducting a research study to evaluate a potential new treatment using CBD for symptoms of anxiety or stress in adults with chronic pain. Local contact Taryn Houghton – Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0285 Trial status Completed
	Diffuse Cutaneous Systemic Sclerosis (dcSSc) Clinical Research A clinical trial to investigate a new treatment for dcSSc. We are seeking participants aged 18-74 with a clinical diagnosis of dcSSc. Local contact Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0286 Trial status Completed
	Investigational Respiratory Syncytial Virus ( RSV ) vaccine trial We are conducting a research study to determine whether an investigational respiratory syncytial virus ( RSV ) vaccine can be given at the same time as an annual flu vaccine Local contact Viviana Silva or Bernardine Easton – Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 567 80398 Trial status Completed	Find out more
	Allergic Rhinitis Study Griffith University is undertaking a research trial examining the effect of a probiotic supplement on hay fever (allergic rhinitis) symptoms. Local contact Rebecca Ramsay/Probiotic study team Email probiotic-study@griffith.edu.au Telephone 0422381424 Trial status Completed	Find out more
	COVID-19 Vaccine Study A clinical study testing a potential Coronavirus (COVID-19) Recombinant Protein Vaccine in healthy adults. Local contact Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0286 Trial status Completed
	Thrush Trial Clinical Trial for efficacy of Intravaginal Combination Therapy of Acetic and Lactic Acid in Recurrent Vulvovaginal Candidiasis (thrush). Local contact Moira Bradfield Strydom- PhD Candidate Email thrushtrial@griffith.edu.au Telephone (07) 5678 0364 or 0400 838 586 Trial status Completed	Find out more
	Major Depressive Disorder (MDD) Study A study to test the effect of different doses of an investigational medication and quetiapine in people diagnosed with Major Depressive Disorder (MDD) that haven’t responded to current anti-depressant medication. Local contact Olga Dopper or Kate Duck – Griffith University Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0350 Trial status Completed
	Stroke Clinical Trial - Perispinal Etanercept Clinical Trial of Perispinal Etanercept in Australian patients with chronic stroke to investigate changes in fatigue and mobility of affected arm. Email contact stroke-interest@griffith.edu.au Trial status Completed
	Meningococcal Vaccine Trial Conducting a clinical trial with a combination meningococcal vaccine compared with two vaccines licensed for use in Australia. Trial status Completed
	Examining Cannabidiol in Healthy Volunteers The study is examining cannabidiol (CBD), the “non-high” component of cannabis over a 24-hour period, to understand how it is absorbed and excreted. We are seeking healthy adults aged between 18 to 60. Trial status Completed
	Allergic Rhinitis/Seasonal Hay Fever Study We are conducting research on a new nasal spray for seasonal Hay Fever. Trial status Completed
	Rheumatoid Arthritis Clinical Research The study is looking for adults who have Rheumatoid Arthritis with swollen and painful joints despite taking conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). Trial status Completed
	Normal levels of a non-human sugar: N-glycolylneuraminic acid (Neu5Gc) This study aims to investigate the levels of a potential new cancer biomarker, the sugar Neu5Gc, in healthy, cancer-free adults (over 18 years) who follow either a strict vegan diet OR regularly consume red meat and dairy. Local contact Anna Fahd Email clinicaltrialunit@griffith.edu.au Telephone (07) 5552 7260	Find out more
	Crohn's Disease Trial A Phase III clinical trial testing an investigational medication for Crohn’s disease. The study doctors are seeking adult volunteers with moderate to severe Crohn’s who have failed treatment with anti-TNF therapy. Local contact Anna Fahd - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5552 7260 Trial status Completed	Find out more
	Crohn's Disease Clinical Research A clinical research study is testing an investigational medication for Crohn's disease. The study doctors are seeking adult volunteers with moderate-to-severe Crohn's who found that a Crohn's medication doesn't work well for them. Local contact Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Trial status Completed
	Papaw Ointment for the Treatment of Sunburn and Insect Bites Conducting a clinical study testing Papaw Ointment as a treatment for mild sunburn and insect bites. Local contact Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone 0419 132 206 Trial status Completed
	Papaw ointment study Conducting a clinical study testing Papaw Ointment as a treatment for superficial wound healing in healthy volunteers. Local contact Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0286 Trial status Completed
	Systemic Lupus Erythematosus (SLE) Clinical Research A study to investigate the Safety and Efficacy of Elsubrutnib and Upadacitinib given alone or in combination in participants with moderately to severe Systemic Lupus Erythematosus (SLE). Local contact Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0368 Trial status Completed
	Alzheimers Disease A randomized, double-blind, placebo-controlled study (and it's extension study) to evaluate the efficacy and safety of ABBV-8E12 in people with early Alzheimer's Disease. Local contact Clinical Trial Unit Telephone (07) 5678 0350 or (07) 5552 7260 Trial status Completed
	Measurement of zinc pyrithione (ZPT) in human serum and urine This study aims to investigate the levels of an antimicrobial agent used in dandruff shampoo (ZPT) in the blood stream following topical application for three consecutive days. Local contact Donna Reeves - Clinical Trial Unit Telephone (07) 5678 0350 Trial status Completed
	Malaria Vaccine Trial This is a Phase 1b trial to examine the effectiveness of a novel malaria vaccine candidate.. Local contact Dr Danielle Stanisic Email glycomicstrials@griffith.edu.au Telephone (07) 5678 0286 Trial status Completed
	Ulcerative Colitis Clinical Research A multicentre, randomised, double-blind, placebo-controlled induction study to evaluate the efficacy and safety of Upadactinib (ABT-494) in subjects with moderately to severely active ulcerative colitis. Local contact Melanie Aikebuse - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Trial status Completed
	Passive Immunisation against Hepatitis A Validating the optimal dose of normal immunoglobulin for protection against Hepatitis A. Local contact Dr Megan Young Email megan.young@griffith.edu.au Telephone (07) 5678 0624
	Normal levels of a non-human sugar: N-glycolylneuraminic acid (NEU5Gc) This study aims to investigate the levels of a potential cancer biomarker, the sugar Neu5Gc, in healthy, cancer-free men and women over the age of 18 before and after fasting. Local contact Dr Lucy Shewell Email Neu5Gclevels@griffith.edu.au
	Anti-Ageing Trial An open label study into the effects of a herbal medicine on cognitive function, quality of life and specific biomarkers associated with age-related decline in older adults. Local contact Evelin Tiralongo - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0366
	Stroke Trial Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke. Local contact A/Prof Stephen Ralph - Menzies Health Institute Queensland Email stroke-interest@griffith.edu.au	For more information - Refer to the publication
	Probiotic and Shift work Study Moderating the effect of sleep disruption/deprivation on gut health and the immune system with probiotics Local contact Rebecca Ramsey Email probiotic-study@griffith.edu.au
	Meningococcal Vaccine Trial Immunogenicity, reactogenicity and safety of two formulations of Meningococcal ACWY conjugate vaccine in healthy adults 18 to 40 years of age. Local contact Donna Reeves - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0350
	Allergic Rhinitis Trial Mapping allergic rhinitis networks: comparative analysis of the effects of a topical antihistamine, topical nasal steroid and a combined antihistamine and steroid on immune phenotype in allergic rhinitis. Local contact Dr Amanda Cox Email allergic.study@griffith.edu.au Telephone (07) 5678 0898
	Ross River Virus Trial A pilot study to investigate the effects of pentosan polysulfate sodium in Ross River virus induced arthralgia. Local contact Danielle O'Reilly - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5552 7260 (07) 5678 0929
	Diabetes Trial Randomised, double-blind placebo controlled dose-ranging study of ZGN-1061 in overweight and obese subjects with Type 2 Diabetes Mellitus to evaluate glycemic control, safety and tolerability over 12 weeks. Local contact Judy Coote - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0286
	Osteoarthritis Trial A Phase 2b, randomised double-blind placebo controlled multi centre study to evaluate the effects of pentosan polysulfate sodium in treating subjects with osteoarthritis of the knee and subchondral bone marrow lesions. Local contact Danielle O'Reilly - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0929
	Memory Recall Trial BioNODS study: Exploring the biochemical relationship between nutrients, oxidative stress, dreams, short-term memory recall and the urine biomarker hydroxyhaemopyrrolin-2-one. Local contact BioNODS research team Email bionods@griffith.edu.au Telephone (07) 5678 0362
	Strep A Diagnostic Device Trial A prospective multi-centre study of the performance of the Ellume-Lab Group A Strep Test versus culture for the rapid detection of Group A Streptococcus in participants with acute Pharyngitis. Local contact Danielle O'Reilly - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5552 7260
	Osteoarthritis Trial A Phase 2A, Randomised, Double-Blind, Placebo-Controlled, Multiple Centre, Multiple-Dose Study to Assess the Efficacy and Safety of ZYN002 Administered as a Transdermal Gel to Patients with Knee Pain due to Osteoarthritis Synthetic Transdermal Cannabidiol for The Treatment of Knee Pain Due to Osteoarthritis Local contact Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0929
	Flu Diagnostic Device Trial A prospective multi-centre study of the Ellume-Lab Flu A+B test and ITreat Flu A+B test performance versus viral culture and reverse transcriptase polymerase chain reaction. Local contact Danielle O'Reilly - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5552 7260
	Malaria Trial A pilot study to examine the persistence and immunogenicity of Plasmodium falciparum 7G8 blood stag parasites following commencement of doxycycline chemoprophylaxis. Local contact Dr Danielle Stanisic Email glycomicstrials@griffith.edu.au Telephone (07) 5552 8051
	Chronic Kidney Disease Trial Dose finding study for Polysialylated Erytrhopoeitin (PSA-EPO) in Chronic Kidney disease (CKD) subjects. Local contact Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0929
	Malaria Trial A pilot study in humans for purified Plasmodium Falciparum 7G8 parasites attenuated with Tafuramycin-A. Local contact Dr Danielle Stanisic Email glycomicstrials@griffith.edu.au Telephone (07) 5552 8051
	Probiotics Trial The effect of probiotics consumption on alcohol pharmacokinetics: A pilot study. Local contact Dr Chris Irwin Email c.irwin@griffith.edu.au Telephone (07) 5678 7344
	Dementia Trial Phase I/II placebo-controlled randomised clinical trial of Etanercept in Australian patients with progressive dementia. Local contact A/Prof. Steve Ralph Email alzheimers-trial@griffith.edu.au
	Malaria Trial A safety and tolerability study in humans for Plasmodium falciparum 7G8 blood stage parasites attenuated with different doses of Tafuramycin-A. Local contact Dr Danielle Stanisic Email glycomicstrials@griffith.edu.au Telephone (07) 5552 8051
	Malaria Trial Infectivity of the Plasmodium falciparum 7G8 malaria cell bank, MCB-004, in humans. Local contact Dr Danielle Stanisic Email glycomicstrials@griffith.edu.au Telephone (07) 5552 8051	For more information - Refer to the publication
	Elderberry Trial Investigating the effectiveness of Elderberry capsules in the prevention of upper respiratory symptoms associated with long distance travel. Local contact A/Prof. Evelin Tiralongo Email e.tiralongo@griffith.edu.au Telephone (07) 5552 7098	For more information - Refer to the publication
	Distribution of carbamazepine in human secretions Investigating the levels of Tregretol in the blood and secretions of women currently taking this drug versus women who are NOT taking Tregretol. Local contact Donna Reeves - Clinical Trial Unit Email CBPtrial@griffith.edu.au
	Peripheral Catheter Trial Impact of PIVC Length and Gauge on Catheter Indwell Time. Local contact Jarod Horobin, PhD – Associate Investigator Email cxlabsconsult@griffith.edu.au Telephone (07) 5552 9564
	Cranberry in recurrent urinary tract infections A randomised, double-blind, placebo controlled study to investigate the efficacy and safety of high strength cranberry in women with recurrent urinary tract infections (Cystitis). Local contact Donna Reeves - Clinical Trial Unit Email clinicaltrialunit@griffith.edu.au Telephone (07) 5678 0350